Haploidentical HCT for Severe Aplastic Anemia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Haploidentical HCT for Severe Aplastic Anemia — Stella

Home/Aplastic Anemia/

View on ClinicalTrials.gov

Recruiting

Back to Aplastic Anemia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

St. Jude Children's Research Hospital, Memphis, Tennessee

Key details

Phase

Safety & dosing

Sponsor

St. Jude Children's Research Hospital

Enrollment target

~21 participants

Started

January 2021

Primary completion

July 2029

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.